Significant improvement from chronic beryllium disease following corticosteroid pulse therapy

Industrial Health

Volumn 44, Issue 2, 2006, Pages 296-301

  Nagaoka, Kaoru ^a   Yoshida, Tsutomu ^b   Sakakibara, Hiroki ^a   Kurita, Hideki ^a   Taniwaki, Hiroshige ^a   Ono, Yuichiro ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MEIJO UNIVERSITY   (Japan)

Author keywords

Beryllium; Chronic beryllium disease; Corticosteroid pulse therapy; Diffuse interstitial pulmonary fibrosis; Lymphocyte transformation test

Indexed keywords

BERYLLIUM; COPPER; CORTICOSTEROID; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; ARTICLE; BERYLLIOSIS; BLOOD GAS ANALYSIS; BRONCHOSCOPY; CASE REPORT; CLINICAL FEATURE; CORTICOSTEROID THERAPY; COUGHING; DISEASE COURSE; DOSE RESPONSE; DRUG PULSE THERAPY; DYSPNEA; FUME; HUMAN; HUMAN CELL; LABORATORY TEST; LUNG BIOPSY; LUNG FUNCTION TEST; MALE; OCCUPATIONAL EXPOSURE; PATIENT MONITORING; THORAX RADIOGRAPHY; WORKPLACE;

ADULT; BERYLLIOSIS; CHRONIC DISEASE; GLUCOCORTICOIDS; HUMANS; JAPAN; MALE; METHYLPREDNISOLONE; PREDNISOLONE; PULSE THERAPY, DRUG;

EID: 33646680064     PISSN: 00198366     EISSN: None     Source Type: Journal    
DOI: 10.2486/indhealth.44.296     Document Type: Article

References (14)

1. Yoshida T (2004) The problems of occupational allergic lung diseases-countermeasures against chronic beryllium disease-. Sangyo Eiseigaku Zasshi 46, 262 (in Japanese).
2. Sterner J, Eisenbud M (1951) Epidemiology of beryllium intoxication. Arch Ind Hyg Occup Med 4, 123-51.
3. Sprince NL, Kazemi H (1980) US beryllium case registry through 1977. Environ Res 212, 44-7.
4. Izumi T, Nishikawa S (1976) Chronic beryllium disease in Japan. Jpn J Chest Dis 35, 805-13 (in Japanese).
5. Suzuki M, Ochi T, Kimura K, Kou M, Miyagawa T, Hamaue S. Kikui M, Takahashi H, Mochizuki T (1986) Chronic beryllium lung disease due to low beryllium contest alloys. Jpn J Chest Dis 46, 138-43 (in Japanese).
6. Hasejima N, Kobayashi H, Takezawa S, Yamato K, Kadoyama C, Kawano Y (1995) Chronic beryllium disease after exposure to low-beryllium-content copper. Jpn J Thoracic Dis 33, 1105-10 (in Japanese).
7. Fujimura N (1984) Study of activated lymphocytes in bronchoalveolar lavage fluid (BALF) from patients with various diffuse interstitial lung diseases. Jpn J Thoracic Dis 22, 552-61 (in Japanese).
8. Maier LA, Raynolds MV, Young DA, Barker EA, Newman LS (1999) Angiotensein-1 converting enzyme polymorphisms in chronic beryllium disease. Am J Respir Crit Care Med 159, 1342-50.
9. Kountz SL, Cohn R (1969) Initial treatment of renal allograft with large intrarenal doses of immunosuppressive drugs. Lancet 1, 338.
10. Yoneda R (1985) Pulse therapy in idiopathic interstitial pneumonia. Respir Res 4, 682-6.
11. Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, Tolley EA (1998) Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome. JAMA 280, 159-65.
12. Van Ordstrand HS (1951) Choice of drugs and dosage. Arch Ind Hyg Occup Med 3, 583-6.
13. Seeler AO (1959) Treatment of chronic beryllium poisoning. AMA Arch Ind Health 19, 289-93.
14. Andrews JL, Kazemi H, Hardy HI (1969) Patterns of lung dysfunction in chronic beryllium disease. Am Rev Respir Dis 1110, 791-800.